149503-79-7 Usage
Uses
Used in Pharmaceutical Industry:
Iefradafiban is used as an orally active prodrug for the treatment of conditions related to fibrinogen receptor antagonists. Its application reason is to provide an alternative method of administration for patients, enhancing the bioavailability and effectiveness of the parent drug, fradafiban.
Used in Research and Development:
Iefradafiban is used as a research compound for studying the mechanisms and effects of fibrinogen receptor antagonists. Its application reason is to contribute to the understanding of the interactions between these antagonists and their target receptors, potentially leading to the development of new therapeutic strategies and treatments for various diseases.
Used in Drug Design and Synthesis:
Iefradafiban is used as a starting point for the design and synthesis of new fibrinogen receptor antagonists. Its application reason is to serve as a template for the development of more potent and selective compounds with improved pharmacological properties, such as better bioavailability, reduced side effects, and increased target specificity.
Check Digit Verification of cas no
The CAS Registry Mumber 149503-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,0 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 149503-79:
(8*1)+(7*4)+(6*9)+(5*5)+(4*0)+(3*3)+(2*7)+(1*9)=147
147 % 10 = 7
So 149503-79-7 is a valid CAS Registry Number.
InChI:InChI=1/C23H25N3O6/c1-30-20(27)12-17-11-18(25-22(17)28)13-32-19-9-7-15(8-10-19)14-3-5-16(6-4-14)21(24)26-23(29)31-2/h3-10,17-18H,11-13H2,1-2H3,(H,25,28)(H2,24,26,29)/t17-,18-/m0/s1
149503-79-7Relevant academic research and scientific papers
Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
-
, (2008/06/13)
Cyclic imino derivatives of the formula wherein A, B, E, X1, X2 and Y are as defined herein, the stereoisomers, tautomers, mixtures and addition salts thereof, pharmaceutical compositions containing these compounds and processes for preparing them. The cyclic imino derivatives are useful as inhibitors of cell-cell and cell-matrix interactions, e.g., thrombocyte aggregation.
Cyclic imino derivatives and pharmaceutical compositions containing them
-
, (2008/06/13)
The invention relates to cyclic imino compounds which have, inter alia, valuable pharmacological properties, especially inhibitory effects on cell aggregation, pharmaceutical compositions which contain these compounds and processes for preparing them.
